Biocon has informed that it enclosed a notification titled ‘Biocon Biologics has fulfilled its obligations towards all deferred milestones under the acquisition agreement with Viatris. This also marks, as full and final remittance of considerations from Biocon Biologics toward Viatris for the acquisition.] The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.